ciprofloxacin has been researched along with Clinically Isolated CNS Demyelinating Syndrome in 1 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Loron, G | 1 |
| Olivier, P | 1 |
| See, H | 1 |
| Le Saché, N | 1 |
| Angulo, L | 1 |
| Biran, V | 1 |
| Brunelle, N | 1 |
| Besson-Lescure, B | 1 |
| Kitzis, MD | 1 |
| Pansiot, J | 1 |
| Bingen, E | 1 |
| Gressens, P | 1 |
| Bonacorsi, S | 1 |
| Baud, O | 1 |
1 other study available for ciprofloxacin and Clinically Isolated CNS Demyelinating Syndrome
| Article | Year |
|---|---|
Ciprofloxacin prevents myelination delay in neonatal rats subjected to E. coli sepsis.
Topics: Animals; Animals, Newborn; Anti-Infective Agents; Ciprofloxacin; Demyelinating Diseases; Escherichia | 2011 |